Viewing Study NCT01101906


Ignite Creation Date: 2025-12-26 @ 3:59 PM
Ignite Modification Date: 2026-01-31 @ 10:37 PM
Study NCT ID: NCT01101906
Status: TERMINATED
Last Update Posted: 2024-11-20
First Post: 2010-04-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
Sponsor: Astellas Pharma Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Hepatocellular Carcinoma (HCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCC View
None OSI-906 View
None Hepatocellular Carcinoma View